Period8 Mar 2021

Media coverage

1

Media coverage

  • TitleXenon Pharmaceuticals Announces Collaboration with Researchers at Icahn School of Medicine at Mount Sinai to Conduct a Phase 2 Study of XEN1101 for the Treatment of Major Depressive Disorder (MDD) Nasdaq:XENE
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date8/03/21
    PersonsJames Murrough